Turn Therapeutics TTRX
NASDAQ TTRX
$14.39 +0.98 (+7.31%)
At close: Sep 30, 2026 · 4:00 PM EDT

Turn Therapeutics (TTRX) Other Non-Current Assets (2024 - 2026)

Updated

Turn Therapeutics (TTRX) reported Other Non-Current Assets of $5.56 million for Q2 2026, down 10.3% from the prior quarter.

Analysis

Turn Therapeutics (TTRX) Other Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Turn Therapeutics posted Other Non-Current Assets of $5.96 million.

  • By year, Other Non-Current Assets came in at $8,582 in FY2024.
  • Five-year quarterly Other Non-Current Assets spans a low of $8,582 in Q4 2024 and a high of $6.2 million in Q1 2026.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $6.2 million (Q1 2026), $5.96 million (Q4 2025) and $8,582 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Turn Therapeutics 428.65 Mn 428.65 Mn - 5.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.56 Mn
Mar 31, 2026 6.20 Mn
Dec 31, 2025 5.96 Mn
Sep 30, 2025 8,582.00
Dec 31, 2024 8,582.00
API Access

Turn Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=TTRX&period=max&api_key=YOUR_API_KEY